TrialHaematologica2013

Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Marlene Troch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.